Literature DB >> 22185999

Therapy-related pure erythroid leukemia with hepatic infiltration and hemophagocytic syndrome.

Yohei Funakoshi1, Hiroshi Matsuoka, Katsuya Yamamoto, Kimikazu Yakushijin, Yumiko Inui, Atsuo Okamura, Mai Takeuchi, Hiroshi Yokozaki, Hironobu Minami.   

Abstract

Pure erythroid leukemia (PEL) is an extremely rare disorder characterized by neoplastic proliferation of immature erythroblasts. A 66-year-old man, who had received chemoradiotherapy for hypopharyngeal cancer, was admitted because of pancytopenia. Bone marrow was infiltrated with 81% proerythroblasts positive for CD71 and CD235a. An increased number of macrophages with active hemophagocytosis was also present. Chromosome analysis showed hypodiploid complex abnormalities. The patient died of progressive disease despite induction chemotherapy. Erythroblastic infiltration into the liver and hemophagocytosis in the spleen were found at autopsy. Therapy-related PEL with hemophagocytic syndrome and hepatic infiltration of PEL has never been reported.

Entities:  

Mesh:

Year:  2011        PMID: 22185999     DOI: 10.2169/internalmedicine.50.6168

Source DB:  PubMed          Journal:  Intern Med        ISSN: 0918-2918            Impact factor:   1.271


  2 in total

1.  Pure erythroid leukemia in advanced breast cancer.

Authors:  Pasquale Niscola; Andrea Tendas; Mauro Minelli; Alessio Perrotti; Paolo de Fabritiis; Giovanni Del Poeta
Journal:  Blood Res       Date:  2014-03-24

2.  Challenging Diagnosis of Pure Erythroid Leukemia: A Case Report and Literature Review.

Authors:  Shingo Sato; Masayuki Kobayashi; Ken Suzaki; Ittoku Nanke; Nobuharu Kosugi
Journal:  Hematol Rep       Date:  2022-03-19
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.